Search Results for: viacyte

Advanced Cell Technology pub: Trial for Macular Degeneration

ACT-FIgure-1-

The stem cell biotech Advanced Cell Technology (ACT) reported new, positive data in a paper in Lancet from their clinical trials using retinal pigmented epithelial cells (RPEs) made from human embryonic stem cells (hESC) for treatment of different forms of macular degeneration (MD). The paper was entitled “Human embryonic stem cell-derived retinal pigment epithelium in patients with age-related …

Advanced Cell Technology pub: Trial for Macular Degeneration Read More »

Takeaways From Harvard Stem Cells for Diabetes Paper

Harvard-stem-cells-Diabetes

The idea of using stem cells for treat Type I Diabetes is very promising and could have huge practical impact. Real progress has been achieved toward this goal over the last decade. In perhaps another decade there might be a validated treatment. A new stem cell paper has just come out in Cell from Harvard in this …

Takeaways From Harvard Stem Cells for Diabetes Paper Read More »

Stem Cell Person of the Year 2014 Award: Vote To Choose 12 Finalists

Stem-Cell-Symbol

Nominations have closed and we have more than two dozen nominations for Stem Cell Person of the Year 2014. It’s an exciting, diverse group including some news faces as well as nominees from years past as well. Happy Stem Cell Day! You can now vote for your choice for the top finalists in the poll …

Stem Cell Person of the Year 2014 Award: Vote To Choose 12 Finalists Read More »

Key questions for stem cell field bouncing around on a Friday morning

ViaCyte-New-Logo

What are the most interesting questions for the stem cell field in 2014 right now? What’s on your mind? I’m not going to give this deep thought, but rather just list those questions bouncing around at the moment in no particular order. You can see a lot of translational/clinical things are on my mind. I’ve …

Key questions for stem cell field bouncing around on a Friday morning Read More »

ISSCR 2014 Day 2: Navigating Balanced Stem Cell Path to Clinic

turner-leigh

I’ve really enjoyed day 2 of ISSCR 2014. So far this day has already packed in a slew of great talks both in the lecture halls and outside one-on-one with old friends and new ones. How great is that? I’ll focus on just a few highlights to keep it concise. Dubious stem cell clinics and …

ISSCR 2014 Day 2: Navigating Balanced Stem Cell Path to Clinic Read More »

Interview with Robert Klein on CIRM’s Future

What does the future hold for CIRM? I asked former CIRM Board Chair and Prop 71 leader, Robert Klein, about that and more in the interview below. He also says some particularly exciting clinical trial and other developments in the stem cell field are coming soon. What got you excited for the very first time …

Interview with Robert Klein on CIRM’s Future Read More »

Stem cells gone wild? What really happens after a transplant

Geron-300x2212

What really happens to cells after they a stem cell transplant into a patient? Once these cells, which have spent weeks in a lab environment, are injected into a person, what happens next? This is arguably the most important question in the regenerative medicine field, but there are few answers. We are literally mostly in …

Stem cells gone wild? What really happens after a transplant Read More »

The valley of death: stem cells, biotechs, and money

For those of us conducting stem cell research, especially human stem cell research, I don’t have to tell you how expensive it is. Even just doing pre-clinical or basic science research costs a fortune. When you start talking about the kind of pre-clinical research specifically designed to get in the near future to a Phase …

The valley of death: stem cells, biotechs, and money Read More »